Teva Wins $176M From Eli Lilly In Migraine Drug Patent Trial

By Brian Dowling · November 9, 2022, 6:59 PM EST

A Boston federal jury on Wednesday ordered Eli Lilly & Co. to pay $176.5 million to Teva Pharmaceuticals after finding that its migraine drug Emgality willfully infringed three Teva patents....

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Teva Pharmaceuticals International GmbH et al v. Eli Lilly and Company

Case Number

1:18-cv-12029

Court

Massachusetts

Nature of Suit

Patent

Date Filed

September 27, 2018